Your browser doesn't support javascript.
loading
MiR-320b and miR-320d as Biomarkers to Predict and Participate in the Formation of Platinum Resistance in Ovarian Cancer Patients.
Liu, Yuan-Yuan; Zhao, Ren-Feng; Liu, Chao; Zhou, Jie; Yang, Liu; Li, Li.
Affiliation
  • Liu YY; Department of Gynecologic Oncology, Guangxi Medical University Cancer Hospital, Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Ministry of Education, Nanning, China.
  • Zhao RF; Department of Gynecology, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
  • Liu C; Department of Gynecology, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
  • Zhou J; Department of Gynecology, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
  • Yang L; Department of Gynecology, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
  • Li L; Department of Gynecology, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
Front Oncol ; 12: 881496, 2022.
Article in En | MEDLINE | ID: mdl-35592674
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Front Oncol Year: 2022 Document type: Article Affiliation country: China Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Front Oncol Year: 2022 Document type: Article Affiliation country: China Country of publication: Switzerland